Page 45 - GPD-2-1
P. 45
Gene & Protein in Disease Therapeutic opportunities in hydrogen sulfide for cancer research
oxide-and hydrogen sulfide-releasing hybrid has enhanced 238. Kashfi K, Chattopadhyay M, Kodela R, 2015, NOSH-
chemo-preventive properties compared to aspirin, is sulindac (AVT-18A) is a novel nitric oxide-and hydrogen
gastrointestinal safe with all the classic therapeutic sulfide-releasing hybrid that is gastrointestinal safe and
indications. Biochem Pharmacol, 98(4): 564–572. has potent anti-inflammatory, analgesic, antipyretic, anti-
platelet, and anti-cancer properties. Redox Biol, 6: 287–296.
https://doi.org/10.1016/j.bcp.2015.09.014
https://doi.org/10.1016/j.redox.2015.08.012
229. Chattopadhyay M, Kodela R, Kashfi K, 2013, P09
therapeutic potential of NOSH-aspirin, a dual nitric oxide- 239. You J, Shi X, Liang H, et al., 2017, Cystathionine-γ-lyase
and hydrogen sulfide-donating hybrid in colon cancer. promotes process of breast cancer in association with
Nitric Oxide, 31: S37–S38. STAT3 signaling pathway. Oncotarget, 8(39): 65677–65686.
https://doi.org/10.1016/j.niox.2013.06.071 https://doi.org/10.18632/oncotarget.20057
230. Kashfi K, Chattopadhyay M, Kodela R, et al., 2013 NOSH‐ 240. You J, Ma M, Ye J, et al., 2017, Down-Regulation of
aspirin a Dual Nitric Oxide and Hydrogen Sulfide‐Releasing Cystathionine-γ-lyase/H2S System Inhibits Cell Growth in
Hybrid Reciprocally Regulates NF‐κB: S‐Nitrosylation vs S‐ Human Breast Cancer MDA-MB-231 Cells. In: BIO Web
Sulfhydration. Hoboken, New Jersey: Wiley Online Library. of Conferences. EDP Sciences.
231. Kashfi K, Borgo S, Williams JL, et al., 2005, Positional 241. Chakraborty PK, Xiong X, Mustafi SB, et al., 2015, Role of
isomerism markedly affects the growth inhibition of colon cystathionine beta synthase in lipid metabolism in ovarian
cancer cells by nitric oxide-donating aspirin in vitro and cancer. Oncotarget, 6(35): 37367–37384.
in vivo. J Pharmacol Exp Ther, 312(3): 978–988.
https://doi.org/10.18632/oncotarget.5424
https://doi.org/10.1124/jpet.104.075994
242. Liu Y, Wang L, Zhang X, et al., 2021, A novel cystathionine
232. Togashi A, Katagiri T, Ashida S, et al., 2005, Hypoxia- γ-lyase inhibitor, I194496, inhibits the growth and
inducible protein 2 (HIG2), a novel diagnostic marker for metastasis of human TNBC via downregulating multiple
renal cell carcinoma and potential target for molecular signaling pathways. Sci Rep, 11(1): 1–13.
therapy. Cancer Res, 65(11): 4817–4826.
243. Ye F, Li X, Sun K, et al., 2020, Inhibition of endogenous
https://doi.org/10.1158/0008-5472.CAN-05-0120 hydrogen sulfide biosynthesis enhances the anti-cancer
effect of 3, 3’-diindolylmethane in human gastric cancer
233. Huang Z, Fu J, Zhang Y, 2017, Nitric oxide donor-based
cancer therapy: Advances and prospects. J Med Chem, cells. Life Sci, 261: 118348.
60(18): 7617–7635. https://doi.org/10.1016/j.lfs.2020.118348
https://doi.org/10.1021/acs.jmedchem.6b01672 244. Yin P, Zhao C, Li Z, et al., 2012, Sp1 is involved in regulation
of cystathionine γ-lyase gene expression and biological
234. Jeong CH, Ryu H, Kim DH, et al., 2019, Piperlongumine
induces cell cycle arrest via reactive oxygen species function by PI3K/Akt pathway in human hepatocellular
accumulation and IKKβ suppression in human breast carcinoma cell lines. Cell Signal, 24(6): 1229–1240.
cancer cells. Antioxidants (Basel), 8(11): 553. https://doi.org/10.1016/j.cellsig.2012.02.003
https://doi.org/10.3390/antiox8110553 245. Pan Y, Ye S, Yuan D, et al., 2014, Hydrogen sulfide (H2S)/
cystathionine γ-lyase (CSE) pathway contributes to the
235. Chattopadhyay M, Kodela R, Santiago G, et al., 2020,
NOSH-aspirin (NBS-1120) inhibits pancreatic cancer proliferation of hepatoma cells. Mutat Res, 763–764: 10–18.
cell growth in a xenograft mouse model: Modulation of https://doi.org/10.1016/j.mrfmmm.2014.03.002
FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS. Biochem 246. Pan Y, Zhou C, Yuan D, et al., 2016, Radiation exposure
Pharmacol, 176: 113857.
promotes hepatocarcinoma cell invasion through epithelial
https://doi.org/10.1016/j.bcp.2020.113857 mesenchymal transition mediated by H2S/CSE pathway.
Radiat Res, 185(1): 96–105.
236. Kodela R, Chattopadhyay M, Kashfi K, 2013, Synthesis and
biological activity of NOSH-naproxen (AVT-219) and NOSH- https://doi.org/10.1667/RR14177.1
sulindac (AVT-18A) as potent anti-inflammatory agents with 247. Yang D, Li T, Li Y, et al., 2019, H2S suppresses indoleamine
chemotherapeutic potential. Medchemcomm, 4(11): 1472–1481.
2, 3-dioxygenase 1 and exhibits immunotherapeutic
https://doi.org/10.1039/C3MD00185G efficacy in murine hepatocellular carcinoma. J Exp Clin
Cancer Res, 38(1): 88.
237. Jia H, Ye J, You J, et al., 2017, Role of the cystathionine
β-synthase/H2S system in liver cancer cells and the https://doi.org/10.1186/s13046-019-1083-5
inhibitory effect of quinolone-indolone conjugate QIC2 on 248. Fan K, Li N, Qi J, et al., 2014, Wnt/β-catenin signaling
the system. Oncol Rep, 37(5): 3001–3009.
induces the transcription of cystathionine-γ-lyase, a
https://doi.org/10.3892/or.2017.5513 stimulator of tumor in colon cancer. Cell Signal, 26(12):
Volume 2 Issue 1 (2023) 30 https://doi.org/10.36922/gpd.v2i1.164

